Get started
Live feed
NEWSReleasevia Quantisnow
Telomir Pharmaceuticals Inc. logo

Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for TELO

Across the 7 sessions after earlier TELO headlines, the stock closed higher 4 times and lower 3 times, with a median move of 7.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

TELO close-to-close change in the session after earlier headlines
SessionEarlier headlineTELOSPY
Jan 5, 2026Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models+11.2%+0.7%
Dec 18, 2025Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development+1.5%+0.8%
Nov 25, 2025Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells+3.1%+0.9%
Nov 21, 2025Telomir Pharmaceuticals Announces Telomir-1 Kills Aggressive Human Leukemia Cells-7.9%+1.0%
Nov 12, 2025Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line-4.9%+0.1%
Oct 23, 2025Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer's "Kill-and-Clean" Defense Systems in an Aggressive Prostate Cancer Model, Outperforming Rapamycin and Chemo+7.2%+0.6%

Keep researching TELO

Quantisnow market dataNASDAQ
Telomir Pharmaceuticals Inc. logo
TELO
Telomir Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2024
Get push alerts for TELO

Follow TELO and get a push notification the moment its next story breaks.

Full TELO profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TELO (Telomir Pharmaceuticals Inc.) and more on Quantisnow.